Literature DB >> 3227041

Scopolamine in rats impairs acquisition but not retention in a 14-unit T-maze.

E L Spangler1, M E Chachich, D K Ingram.   

Abstract

To follow up a previous report noting that scopolamine impaired acquisition performance of young rats in a shock-motivated 14-unit T-maze, the present study assessed the effects of muscarinic antagonism on retention aspects of the same task. The broader objective was to further the investigation of possible defects in cholinergic neurotransmission that might underlie the age-related impairments previously observed in this task. Young (3-month) male F-344 rats were given preliminary training to criterion in one-way active avoidance in a straight runway. Then on the first day of complex maze training, each rat received 5 acquisition (AQ) trials followed by a second 10-trial retention (RET) session conducted the following day. Subjects were assigned to one of eight groups receiving an intraperitoneal injection of either scopolamine hydrochloride (1.0 mg/kg) or saline as follows: (a) 30 min prior to training on the first day (PRE-AQ); (b) 30 min prior to training on both the first and second day (PRE-AQ-RET); (c) immediately after completing the trial on the first day (POST-AQ); (d) 30 min prior to testing on the second day (PRE-RET). Dependent measures included errors, alternation errors, run time, number of shocks, and total shock received. On the first day of maze training, all performance measures except for alternation errors were significantly higher for the two acquisition groups (PRE-AQ and PRE-AQ-RET) compared to all other groups which did not differ significantly.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3227041     DOI: 10.1016/0091-3057(88)90125-6

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  6 in total

1.  Phosphodiesterase inhibition by sildenafil citrate attenuates a maze learning impairment in rats induced by nitric oxide synthase inhibition.

Authors:  Bryan D Devan; Jonna L Bowker; Kara B Duffy; Ila S Bharati; Mariana Jimenez; Demetrio Sierra-Mercado; Christopher M Nelson; Edward L Spangler; Donald K Ingram
Journal:  Psychopharmacology (Berl)       Date:  2005-11-18       Impact factor: 4.530

2.  Sex-dependent metabolic, neuroendocrine, and cognitive responses to dietary energy restriction and excess.

Authors:  Bronwen Martin; Michele Pearson; Lisa Kebejian; Erin Golden; Alex Keselman; Meredith Bender; Olga Carlson; Josephine Egan; Bruce Ladenheim; Jean-Lud Cadet; Kevin G Becker; William Wood; Kara Duffy; Prabhu Vinayakumar; Stuart Maudsley; Mark P Mattson
Journal:  Endocrinology       Date:  2007-06-14       Impact factor: 4.736

3.  Phenserine: a physostigmine derivative that is a long-acting inhibitor of cholinesterase and demonstrates a wide dose range for attenuating a scopolamine-induced learning impairment of rats in a 14-unit T-maze.

Authors:  S Iijima; N H Greig; P Garofalo; E L Spangler; B Heller; A Brossi; D K Ingram
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  A comparison of the effects of scopolamine and diazepam on acquisition and retention of inhibitory avoidance in mice.

Authors:  M W Decker; T Tran; J L McGaugh
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Scopolamine impairs delayed matching in an olfactory task in rats.

Authors:  N Ravel; M Vigouroux; A Elaagouby; R Gervais
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Possible overlapping time frames of acquisition and consolidation phases in object memory processes: a pharmacological approach.

Authors:  Sven Akkerman; Arjan Blokland; Jos Prickaerts
Journal:  Learn Mem       Date:  2015-12-15       Impact factor: 2.460

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.